Crescent Capital III is a venture capital fund part funded by the European Regional Development Fund under the EU Investment for Growth and Jobs Programme 2014-2020 – Crescent Capital III
FIND OUT MORE

News from Crescent and our Investees

Belfast-Power

Plans revealed for £280 million Belfast Power Station Project

Plans have been officially unveiled for a state-of-the-art, gas-fired power station in the Belfast Harbour Estate. The Belfast Power... Find Out More
pathxl logo

PathXL: Belfast-based medical software firm sold to Philips

BELFAST, 21 June 2016.  The Belfast-based digital pathology firm, PathXL, has been sold to the multinational health technology company,... Find Out More

Artificial Intelligence Firm Ampliphae

BELFAST, 22 June 2016:  Enterprise, Trade and Investment Minister Jonathan Bell has announced Belfast-based technology company Ampliphae is to... Find Out More

Fusion Antibodies Strike Green!

BELFAST, 5 February 2016: Fusion Antibodies opened the year 2016 with a flourish as a recipient of one of... Find Out More

Genesys snaps up SpeechStorm

BELFAST, 18 December 2015 – SpeechStorm has been acquired by the US Company Genesys. SpeechStorm was backed in a... Find Out More

Analytics Engines deliver significant runtime improvements for Almac

BELFAST, March 2015:  Almac had identified a bottleneck in their bioinformatics workflow relating to gap statistic. Gap statistic is... Find Out More